Clinical Genetics · 2021 · 29 citations · 8 references
MedicineGeneticsMolecular GeneticsAutism Spectrum DisordersGenomicsHuman GeneticsAutism Spectrum Disorder GeneticsCopy Number Variant AnalysisCopy Number VariantsGenetic DisordersNeurodevelopmental DisordersNeurogenetic DisordersAutism Spectrum Disorder Copy Number VariantsChromosomal Microarray AnalysisCopy Number Variant InterpretationCopy Number Variant PathogenicityGenome-wide Copy Number Variation AnalysisMicroarray AnalysisPathogenic Copy Number VariantsRare Copy Number Variants
Prediction of pathogenicity of rare copy number variations (CNVs), a genomic alteration known to contribute to the etiology of autism spectrum disorder (ASD), represents a serious limitation to interpreting genetic tests, particularly for genetic counseling purposes. Chromosomal microarray analysis (CMA) was conducted in a unique collection of 144 Brazilian individuals with ASD of strong European and African ancestries. Rare CNVs were detected in 39 patients: 41 of unknown significance (VUS), four pathogenic and one likely pathogenic CNVs (clinical yield of 4.1%; 5/122). Based on gene content and recurrence in three large cohorts [a Brazilian neurodevelopmental disorder cohort, the autism MSSNG cohort, and the Canadian-based Centre for Applied Genomics microarray database], this work strengthened the pathogenicity of 14 genes (FAT1, CAMK4, BIRC6, DPP6, CSMD1, CTNNA3, CDH8/CDH11, CDH13, OR1C1, CNTN6, CNTNAP4, FGF2 and PTPRN2) within 14 CNVs. Notably, enrichment of cell adhesion proteins to ASD etiology was identified (p < 0.05), highlighting the importance of these gene families in the etiology of ASD.
8
Hutton M. Kearney, Erik C. Thorland, Kerry K. Brown et al. · Genetics in Medicine · 2011 · 956 citations · Full text
M-L Jacquemont, Damien Sanlaville, Richard Redon et al. · Journal of Medical Genetics · 2006 · 304 citations · Full text